Insights

Scale-down models have become an increasingly common development tool, especially in the bioprocessing industry. Read our eBook to discover our approach to the challenge of scaling up scale down models.

Sepsis is a life-threatening response of the immune system to infection that can lead to tissue damage, organ failure and the risk of permanent disability or death. Detecting and treating it early can be highly effective in stopping progression. The trouble is that implementing the level of monitoring required to catch sepsis at the earliest stages is tough outside critical care settings. 

Patient monitoring is an inherent part of patient management. Intermittent and continuous measurements have a range of uses, from defining disease states and characterising progression to informing therapeutic approaches and...

Biology, chemistry, engineering and AI are obviously very different disciplines. But our determination to make them work closely together has enabled some truly remarkable progress. Symon Cotton, Head of Life Sciences, says that harnessing these fields and embracing the different ways scientists and engineers work has improved the development of breakthrough medical products…  

The pandemic has accelerated our path towards an inevitable conclusion – a digitally connected healthcare future that empowers both patients and carers alike. The opportunities are out there, so what’s the next step for pharma companies and device developers with ambitions in the space? 

From almost three years of pandemic restrictions to a three-day biology bonanza. Senior Biomedical Engineer Ellen Simmons gets back on the live conference trail with a visit to Built With Biology, formerly SynBioBeta. Here she shares her experiences – and enthusiasm for helping to drive the biotech ecosystem forwards… 

Our brand relaunch has landed just as we ramp up our commitment to The Engine, the ambitious venture capital firm spun out of MIT (Massachusetts Institute of Technology) to support ‘Tough Tech’ companies and solve key challenges in climate change, human health and advanced systems. What’s particularly energizing is that as a strategic partner, we get to engage with founders of disruptive start-ups who are so passionate, driven and mission focused. The alignment with our own renewed purpose couldn’t be stronger.

The ability to count and track individual units of light can have an exciting range of applications across medtech and beyond, as a recent collaboration with Cambridge University has proved. Principal electronics engineer Oliver Hicks explains more…

Dr Ashwini Sharan and Cambridge Consultants recently provoked debate with the release of a visionary film, ‘A day in the life of a Parkinson’s patient in 2030’, which imagined seamless therapy enabled by smart implants, surgical robotics, digital connectivity and AI. Here, Ash explains why his ambitions for the future of medicine are not just blue-sky thinking but a rallying cry for the healthcare world… 

Philosophically speaking, should we be designing systems that autonomously control both accuracy and precision for the best outcome of the patient? Andy Savarese explores some of the deeper questions that are starting to be asked by clients – and looks ahead as the role of robotics continues to evolve.

Photonics promises to revolutionise health monitoring. As Rockley Photonics expands its digital capabilities with a new class of optical sensor, Tom Watson explores the wider potential in areas such as personalised medicine – and provides insight into overcoming the key challenges that lie ahead.

The current state of in vitro diagnostics is no longer fit for purpose. In vitro diagnostics needs seismic change to improve patient outcomes and deliver economic benefits...